10-K Filing

MEDICAL INNOVATION HOLDINGS, INC. CIK: 1093248 FY 2016

Filing Information

Filing Contents

This filing contains the following financial statements:

Balance Sheet 18 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	372.09M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$1.60K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	372.09M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.60K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.60K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$203.64K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$441.93K	USD	Point-in-time
Related Parties - short-term borrowings from shareholders	`DueToOfficersOrStockholdersCurrent`	$18.10K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$663.67K	USD	Point-in-time
Common stock, $0.0001 par value, 500,000,000 shares authorized 372,090,000 shares issued and outstanding on April 30, 2016	`CommonStockValue`	$37.21K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$-37.21K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-662.07K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-662.07K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	-	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$1.60K	USD	Point-in-time

Income Statement 8 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	-	USD	Annual
Asset impairment	`AssetImpairmentCharges`	$662.07K	USD	Annual
Total operating expenses	`OperatingExpenses`	$662.07K	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$662.07K	USD	Annual
Income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-662.07K	USD	Annual
Net loss per common share Basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
Weighted average number of common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	372.09M	shares	Annual

Cash Flow Statement 14 line items

Line Item	Tag	Value	Unit	Period
Net loss attributable to common stockholders	`NetIncomeLoss`	$-662.07K	USD	Annual
Impairment of asset	`AssetImpairmentCharges`	$662.07K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-16.50K	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.50K	USD	Annual
Net cash (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Due to Shareholders	`ProceedsFromRelatedPartyDebt`	$18.10K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.10K	USD	Annual
NET CHANGE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.60K	USD	Annual
CASH, Beginning	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH, Beginning	`CashAndCashEquivalentsAtCarryingValue`	$1.60K	USD	Point-in-time
CASH, Ending	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH, Ending	`CashAndCashEquivalentsAtCarryingValue`	$1.60K	USD	Point-in-time
Interest paid	`InterestPaid`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	Annual

Stockholders Equity 7 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-662.07K	USD	Point-in-time
Balance	`StockholdersEquity`	-	USD	Point-in-time
Shares issued on reverse merger	`StockIssuedDuringPeriodValueAcquisitions`	-	USD	Annual
Recapitalization of shares	`StockIssuedDuringPeriodValueNewIssues`	-	USD	Annual
Net loss for the period	`NetIncomeLoss`	$-662.07K	USD	Annual
Balance	`StockholdersEquity`	$-662.07K	USD	Point-in-time
Balance	`StockholdersEquity`	-	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.